Numenos
2 known investors
Find your way into Numenos
Sign up to see every warm intro you have to Numenos
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Numenos team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Numenos builds patient-centric biological world models that learn from individual patient data across all diseases to discover the causal mechanisms underlying human biology. The platform applies machine learning to biology with the aim of enabling individualized treatments.
Founders & leadership
AW

Amit WeissFounderFounder of Numenos, which builds patient-centric biological world models that apply machine learning to individual patient data to identify causal mechanisms in human biology and support individualized treatments. An IDF Talpiot alumnus, he has worked as a manager and researcher across a range of organizations, technologies, and scientific fields, with an interest in healthcare.
Investors · 2
Meron Capitallisted by Meron CapitalTel Aviv
How we know: Meron Capital's portfolio page · Not right? Tell us
TechAviv Founder PartnersreportedTel Aviv · $500K – $3M
How we know: a partner's Signal profile · Not right? Tell us
Frequently asked questions
- What does Numenos do?
- Numenos builds patient-centric biological world models that learn from individual patient data across all diseases to discover the causal mechanisms underlying human biology. The platform applies machine learning to biology with the aim of enabling individualized treatments.
- Who founded Numenos?
- Numenos was founded by Amit Weiss.
- Who are Numenos's investors?
- Numenos's investors include Meron Capital, TechAviv Founder Partners.
